7Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66(1):34- 45.
8Saag KG, Teng GG, Patkar NM, et al. American college ofrheumatology 2008 recommendations for the use of non biologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum, 2008, 59(6):762-784.
9Weasels JA, de Vries-Bonwstro JK, Heijmans BT, et al. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleetide polymorphiams in genes coding for folate parthway enzymes. Arthritis Rheum, 2006, 54(4):1087- 1095.
10Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31(3):315-324.
